The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe
|
|---|---|
| Published in |
Frontiers in Pharmacology, August 2022
|
| DOI | 10.3389/fphar.2022.924648 |
| Pubmed ID | |
| Authors |
Carla J. Jonker, Elisabeth Bakker, Xavier Kurz, Kelly Plueschke |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Ireland | 1 | 14% |
| Canada | 1 | 14% |
| Switzerland | 1 | 14% |
| Spain | 1 | 14% |
| Unknown | 3 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 46 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 5 | 11% |
| Student > Ph. D. Student | 5 | 11% |
| Other | 4 | 9% |
| Student > Bachelor | 4 | 9% |
| Researcher | 4 | 9% |
| Other | 4 | 9% |
| Unknown | 20 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 20% |
| Medicine and Dentistry | 5 | 11% |
| Nursing and Health Professions | 2 | 4% |
| Social Sciences | 2 | 4% |
| Agricultural and Biological Sciences | 1 | 2% |
| Other | 3 | 7% |
| Unknown | 24 | 52% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 July 2023.
All research outputs
#5,898,712
of 24,174,783 outputs
Outputs from Frontiers in Pharmacology
#2,405
of 18,038 outputs
Outputs of similar age
#105,742
of 420,294 outputs
Outputs of similar age from Frontiers in Pharmacology
#107
of 1,378 outputs
Altmetric has tracked 24,174,783 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 18,038 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 420,294 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 1,378 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.